Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,204.20 -9.71 (-0.80%)

Streaming Delayed Price Updated: 3:27 PM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down ↗

June 02, 2026

An upcoming trial result could change how investors think about the weight-loss drug market.

Via The Motley Fool

Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. ↗

June 02, 2026

Expense ratios, asset size, and portfolio strategy set these two healthcare ETFs apart, yet their risk and dividend profiles tell a different story.

Via The Motley Fool

Topics ETFs

State Street's Health Care ETF Tops Invesco's on Yield and Returns ↗

June 02, 2026

Expense ratios, dividend yields, and risk profiles set these healthcare ETFs apart. See how their strategies shape long-term performance for investors.

Via The Motley Fool

Topics ETFs

Eli Lilly & Co. (NYSE:LLY) Ranks as a Textbook Growth Stock ↗

June 01, 2026

Via Chartmill

Trump Said 'Micron's Great'—And Now Micron's Worth More Than Walmart, Eli Lilly, Berkshire Hathaway ↗

June 01, 2026

Micron Technology just became the 12th-biggest company in the world, bigger than Berkshire Hathaway. UBS sees another 56% upside as June 24 earnings near.

Via Benzinga

Topics Government

U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗

June 01, 2026

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S....

Via The Motley Fool

Topics ETFs Intellectual Property

These 8 Words From Eli Lilly's CEO Have Wall Street Turning Bullish ↗

June 01, 2026

David Ricks was addressing the pharmaceutical titan's latest hot product.

Via The Motley Fool

Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations ↗

June 01, 2026

Eli Lilly signs drug development deals with Hanmi and Haisco as Retevmo Phase 3 data show an 83% cut in recurrence risk.

Via Benzinga

What's going on in today's session: S&P500 gap up and gap down stocks ↗

June 01, 2026

Via Chartmill

Is Eli Lilly Starting an Nvidia-Style Run? ↗

June 01, 2026

Lilly shares soared more than 18% in May.

Via The Motley Fool

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks We Think Twice About

June 01, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1

May 31, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how branded pharmaceutical...

Via StockStory

Topics Artificial Intelligence Intellectual Property

DRAM Memory Boom: Why Micron Stock Could Still Double ↗

May 31, 2026

Micron's share price doubled in 48 days.

Via The Motley Fool

Topics Artificial Intelligence

5 Best Growth Stocks for the Next 10 Years ↗

May 31, 2026

These 5 long-term growth stocks could benefit from AI, cybersecurity, GLP-1 drugs, and fintech trends over the next decade

Via MarketBeat

Topics Artificial Intelligence Economy

Prediction: After Micron and AMD, This Will Be the Next Tech Stock to Join the $1 Trillion Club ↗

May 30, 2026

ASML's lithography machines are needed to manufacture advanced AI processing and memory chips.

Via The Motley Fool

Topics Artificial Intelligence

Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors ↗

May 30, 2026

Eli Lilly is working on a new GLP-1 drug, and early results suggest it could be a big winner.

Via The Motley Fool

The Smartest Growth Stocks to Buy With $2,000 Right Now ↗

May 30, 2026

Most of the market's best-known growth names are overbought at this time. That's not the case for several off-the-radar alternatives.

Via The Motley Fool

Topics Artificial Intelligence

Stock Split Watch: Is Eli Lilly Next? ↗

May 30, 2026

Lilly has split its stock in the past.

Via The Motley Fool

Stock Market Today, May 28: Tech Stocks Rise as Snowflake Surges After $6 Billion Amazon Deal and Strong Earnings ↗

May 28, 2026

Today, May 28, 2026, investors piled into Snowflake after its Amazon pact and earnings beat, even as the Dow barely budged.

Via The Motley Fool

Topics Artificial Intelligence Earnings Economy

Why Eli Lilly (LLY) Stock Is Trading Up Today

May 28, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the afternoon session after CVS restored Zepbound as a co-preferre...

Via StockStory

Why Is Eli Lilly Stock Surging On Thursday? ↗

May 28, 2026

Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity treatments, Zepbound and Foundayo.

Via Benzinga

Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now ↗

May 28, 2026

Novo Nordisk lost its lead in the GLP-1 race, but Eli Lilly's valuation is a bit rich.

Via The Motley Fool

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost ↗

May 28, 2026

Expense ratios, yield, and sector breadth set these healthcare ETFs apart—see how their risk profiles and portfolio strategies compare.

Via The Motley Fool

Topics ETFs

Is Eli Lilly Stock Outperforming the Nasdaq?

May 28, 2026

Eli Lilly has outpaced the Nasdaq Composite over the past year, and analysts remain very confident in its longer-term trajectory.

Via Barchart.com

Topics Stocks

Is Johnson & Johnson Stock Outperforming the Dow?

May 28, 2026

Johnson & Johnson has outperformed the Dow Jones over the past year, and analysts remain moderately optimistic about the stock’s outlook.

Via Barchart.com

Topics Stocks

5 Undervalued Stocks You Can Buy and Hold Forever ↗

May 28, 2026

Buying and holding stocks is an excellent strategy to increase your wealth.

Via The Motley Fool

3 Healthcare Stocks We Keep Off Our Radar

May 28, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...

Via StockStory

2 Mega-Cap Stocks on Our Buy List and 1 We Find Risky

May 28, 2026

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less roo...

Via StockStory

Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried? ↗

May 27, 2026

There is no reason to panic just yet.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Eli Lilly (NY:LLY)

All News about Eli Lilly